Hyperoxaluria after modern bariatric surgery

Case series and literature review

Jared M Whitson, G. Bennett Stackhouse, Marshall L. Stoller

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Introduction Two recent studies have shown that modern bariatric surgery leads to significant hyperoxaluria and risk of nephrolithiasis. However, neither report evaluates the use or effects of stone risk modifying agents in these patients. We sought to determine the impact of medical management on stone risk profile in patients who have undergone Roux-en-y gastric bypass. Materials and methods Twenty-four-hour urine collections of all patients referred to a tertiary clinic for nephrolithiasis in the past 4 years were reviewed. Those patients with severe (>75 mg/day) hyperoxaluria were identified. Retrospective chart review was performed to identify those patients with a history of bariatric surgery. Student's t-test was used to compare mean urinary parameters between bariatric and non-bariatric patients. Results Out of all stone formers within our 24-h urine collection database, 39 patients had severe hyperoxaluria (oxalate >75 mg/day). Twenty-six patients had complete information for review. Five patients had a history of bariatric surgery. Compared with non-bariatric patients, those with a history of bariatric surgery had increased use of oral calcium (80 vs. 28%) and citrate supplementation (100 vs. 47%), higher urinary oxalate (129 vs. 91 mg/day) and volume (2.9 vs. 2.4 L/day), lower urinary citrate (390 vs. 800 mg/day) and calcium (155 vs. 235 mg/day), and a decreased supersaturation of calcium oxalate (6.7 vs. 11). Conclusions Appropriate medical management, in particular oral calcium and citrate supplementation, and perhaps most importantly aggressive fluid intake can mitigate some of the effects of enteric hyperoxaluria caused by fat malabsorption after modern bariatric surgery.

Original languageEnglish (US)
Pages (from-to)369-374
Number of pages6
JournalInternational Urology and Nephrology
Volume42
Issue number2
DOIs
StatePublished - Jun 2010
Externally publishedYes

Fingerprint

Hyperoxaluria
Bariatric Surgery
Nephrolithiasis
Urine Specimen Collection
Oxalates
Citric Acid
Calcium Citrate
Calcium
Bariatrics
Calcium Oxalate
Gastric Bypass
Proxy
Fats
Databases
Students

Keywords

  • Bariatric surgery
  • Calcium oxalate
  • Obesity
  • Urinary calculi

ASJC Scopus subject areas

  • Nephrology
  • Urology

Cite this

Hyperoxaluria after modern bariatric surgery : Case series and literature review. / Whitson, Jared M; Stackhouse, G. Bennett; Stoller, Marshall L.

In: International Urology and Nephrology, Vol. 42, No. 2, 06.2010, p. 369-374.

Research output: Contribution to journalArticle

Whitson, Jared M ; Stackhouse, G. Bennett ; Stoller, Marshall L. / Hyperoxaluria after modern bariatric surgery : Case series and literature review. In: International Urology and Nephrology. 2010 ; Vol. 42, No. 2. pp. 369-374.
@article{32bb9906f18f4563b00c3af2e92d2703,
title = "Hyperoxaluria after modern bariatric surgery: Case series and literature review",
abstract = "Introduction Two recent studies have shown that modern bariatric surgery leads to significant hyperoxaluria and risk of nephrolithiasis. However, neither report evaluates the use or effects of stone risk modifying agents in these patients. We sought to determine the impact of medical management on stone risk profile in patients who have undergone Roux-en-y gastric bypass. Materials and methods Twenty-four-hour urine collections of all patients referred to a tertiary clinic for nephrolithiasis in the past 4 years were reviewed. Those patients with severe (>75 mg/day) hyperoxaluria were identified. Retrospective chart review was performed to identify those patients with a history of bariatric surgery. Student's t-test was used to compare mean urinary parameters between bariatric and non-bariatric patients. Results Out of all stone formers within our 24-h urine collection database, 39 patients had severe hyperoxaluria (oxalate >75 mg/day). Twenty-six patients had complete information for review. Five patients had a history of bariatric surgery. Compared with non-bariatric patients, those with a history of bariatric surgery had increased use of oral calcium (80 vs. 28{\%}) and citrate supplementation (100 vs. 47{\%}), higher urinary oxalate (129 vs. 91 mg/day) and volume (2.9 vs. 2.4 L/day), lower urinary citrate (390 vs. 800 mg/day) and calcium (155 vs. 235 mg/day), and a decreased supersaturation of calcium oxalate (6.7 vs. 11). Conclusions Appropriate medical management, in particular oral calcium and citrate supplementation, and perhaps most importantly aggressive fluid intake can mitigate some of the effects of enteric hyperoxaluria caused by fat malabsorption after modern bariatric surgery.",
keywords = "Bariatric surgery, Calcium oxalate, Obesity, Urinary calculi",
author = "Whitson, {Jared M} and Stackhouse, {G. Bennett} and Stoller, {Marshall L.}",
year = "2010",
month = "6",
doi = "10.1007/s11255-009-9602-5",
language = "English (US)",
volume = "42",
pages = "369--374",
journal = "International Urology and Nephrology",
issn = "0301-1623",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Hyperoxaluria after modern bariatric surgery

T2 - Case series and literature review

AU - Whitson, Jared M

AU - Stackhouse, G. Bennett

AU - Stoller, Marshall L.

PY - 2010/6

Y1 - 2010/6

N2 - Introduction Two recent studies have shown that modern bariatric surgery leads to significant hyperoxaluria and risk of nephrolithiasis. However, neither report evaluates the use or effects of stone risk modifying agents in these patients. We sought to determine the impact of medical management on stone risk profile in patients who have undergone Roux-en-y gastric bypass. Materials and methods Twenty-four-hour urine collections of all patients referred to a tertiary clinic for nephrolithiasis in the past 4 years were reviewed. Those patients with severe (>75 mg/day) hyperoxaluria were identified. Retrospective chart review was performed to identify those patients with a history of bariatric surgery. Student's t-test was used to compare mean urinary parameters between bariatric and non-bariatric patients. Results Out of all stone formers within our 24-h urine collection database, 39 patients had severe hyperoxaluria (oxalate >75 mg/day). Twenty-six patients had complete information for review. Five patients had a history of bariatric surgery. Compared with non-bariatric patients, those with a history of bariatric surgery had increased use of oral calcium (80 vs. 28%) and citrate supplementation (100 vs. 47%), higher urinary oxalate (129 vs. 91 mg/day) and volume (2.9 vs. 2.4 L/day), lower urinary citrate (390 vs. 800 mg/day) and calcium (155 vs. 235 mg/day), and a decreased supersaturation of calcium oxalate (6.7 vs. 11). Conclusions Appropriate medical management, in particular oral calcium and citrate supplementation, and perhaps most importantly aggressive fluid intake can mitigate some of the effects of enteric hyperoxaluria caused by fat malabsorption after modern bariatric surgery.

AB - Introduction Two recent studies have shown that modern bariatric surgery leads to significant hyperoxaluria and risk of nephrolithiasis. However, neither report evaluates the use or effects of stone risk modifying agents in these patients. We sought to determine the impact of medical management on stone risk profile in patients who have undergone Roux-en-y gastric bypass. Materials and methods Twenty-four-hour urine collections of all patients referred to a tertiary clinic for nephrolithiasis in the past 4 years were reviewed. Those patients with severe (>75 mg/day) hyperoxaluria were identified. Retrospective chart review was performed to identify those patients with a history of bariatric surgery. Student's t-test was used to compare mean urinary parameters between bariatric and non-bariatric patients. Results Out of all stone formers within our 24-h urine collection database, 39 patients had severe hyperoxaluria (oxalate >75 mg/day). Twenty-six patients had complete information for review. Five patients had a history of bariatric surgery. Compared with non-bariatric patients, those with a history of bariatric surgery had increased use of oral calcium (80 vs. 28%) and citrate supplementation (100 vs. 47%), higher urinary oxalate (129 vs. 91 mg/day) and volume (2.9 vs. 2.4 L/day), lower urinary citrate (390 vs. 800 mg/day) and calcium (155 vs. 235 mg/day), and a decreased supersaturation of calcium oxalate (6.7 vs. 11). Conclusions Appropriate medical management, in particular oral calcium and citrate supplementation, and perhaps most importantly aggressive fluid intake can mitigate some of the effects of enteric hyperoxaluria caused by fat malabsorption after modern bariatric surgery.

KW - Bariatric surgery

KW - Calcium oxalate

KW - Obesity

KW - Urinary calculi

UR - http://www.scopus.com/inward/record.url?scp=77956191232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956191232&partnerID=8YFLogxK

U2 - 10.1007/s11255-009-9602-5

DO - 10.1007/s11255-009-9602-5

M3 - Article

VL - 42

SP - 369

EP - 374

JO - International Urology and Nephrology

JF - International Urology and Nephrology

SN - 0301-1623

IS - 2

ER -